Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Mitochondrial Probe Methyltriphenylphosphonium (TPMP) Inhibits the Krebs Cycle Enzyme 2-Oxoglutarate Dehydrogenase

M. Elkalaf, P. Tůma, M. Weiszenstein, J. Polák, J. Trnka,

. 2016 ; 11 (8) : e0161413. [pub] 20160818

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc17031501

Methyltriphenylphosphonium (TPMP) salts have been widely used to measure the mitochondrial membrane potential and the triphenylphosphonium (TPP+) moiety has been attached to many bioactive compounds including antioxidants to target them into mitochondria thanks to their high affinity to accumulate in the mitochondrial matrix. The adverse effects of these compounds on cellular metabolism have been insufficiently studied and are still poorly understood. Micromolar concentrations of TPMP cause a progressive inhibition of cellular respiration in adherent cells without a marked effect on mitochondrial coupling. In permeabilized cells the inhibition was limited to NADH-linked respiration. We found a mixed inhibition of the Krebs cycle enzyme 2-oxoglutarate dehydrogenase complex (OGDHC) with an estimated IC50 3.93 [3.70-4.17] mM, which is pharmacologically plausible since it corresponds to micromolar extracellular concentrations. Increasing the lipophilic character of the used TPP+ compound further potentiates the inhibition of OGDHC activity. This effect of TPMP on the Krebs cycle ought to be taken into account when interpreting observations on cells and mitochondria in the presence of TPP+ derivatives. Compounds based on or similar to TPP+ derivatives may also be used to alter OGDHC activity for experimental or therapeutic purposes.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17031501
003      
CZ-PrNML
005      
20171025123027.0
007      
ta
008      
171025s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1371/journal.pone.0161413 $2 doi
035    __
$a (PubMed)27537184
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Elkalaf, Moustafa $u Laboratory for Metabolism and Bioenergetics, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Centre for Research on Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
245    10
$a Mitochondrial Probe Methyltriphenylphosphonium (TPMP) Inhibits the Krebs Cycle Enzyme 2-Oxoglutarate Dehydrogenase / $c M. Elkalaf, P. Tůma, M. Weiszenstein, J. Polák, J. Trnka,
520    9_
$a Methyltriphenylphosphonium (TPMP) salts have been widely used to measure the mitochondrial membrane potential and the triphenylphosphonium (TPP+) moiety has been attached to many bioactive compounds including antioxidants to target them into mitochondria thanks to their high affinity to accumulate in the mitochondrial matrix. The adverse effects of these compounds on cellular metabolism have been insufficiently studied and are still poorly understood. Micromolar concentrations of TPMP cause a progressive inhibition of cellular respiration in adherent cells without a marked effect on mitochondrial coupling. In permeabilized cells the inhibition was limited to NADH-linked respiration. We found a mixed inhibition of the Krebs cycle enzyme 2-oxoglutarate dehydrogenase complex (OGDHC) with an estimated IC50 3.93 [3.70-4.17] mM, which is pharmacologically plausible since it corresponds to micromolar extracellular concentrations. Increasing the lipophilic character of the used TPP+ compound further potentiates the inhibition of OGDHC activity. This effect of TPMP on the Krebs cycle ought to be taken into account when interpreting observations on cells and mitochondria in the presence of TPP+ derivatives. Compounds based on or similar to TPP+ derivatives may also be used to alter OGDHC activity for experimental or therapeutic purposes.
650    _2
$a zvířata $7 D000818
650    _2
$a buněčné linie $7 D002460
650    _2
$a citrátsynthasa $x účinky léků $x metabolismus $7 D002950
650    _2
$a citrátový cyklus $x účinky léků $7 D002952
650    _2
$a glutamátdehydrogenasa $x účinky léků $x metabolismus $7 D005969
650    _2
$a isocitrátdehydrogenasa $x účinky léků $x metabolismus $7 D007521
650    _2
$a ketoglutarátdehydrogenasový komplex $x antagonisté a inhibitory $x metabolismus $7 D007655
650    _2
$a malátdehydrogenasa $x účinky léků $x metabolismus $7 D008291
650    _2
$a membránový potenciál mitochondrií $x účinky léků $7 D053078
650    _2
$a svalové mitochondrie $x účinky léků $x enzymologie $7 D008931
650    _2
$a kosterní svaly $x enzymologie $7 D018482
650    _2
$a oniové sloučeniny $x farmakologie $7 D009861
650    _2
$a pyruvátdehydrogenasový komplex $x účinky léků $x metabolismus $7 D011768
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani Wistar $7 D017208
650    _2
$a tritylové sloučeniny $x farmakologie $7 D014320
655    _2
$a časopisecké články $7 D016428
700    1_
$a Tůma, Petr $u Department of Biochemistry, Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Centre for Research on Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Weiszenstein, Martin $u Department of Sport Medicine, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Centre for Research on Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Polák, Jan $u Department of Sport Medicine, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Centre for Research on Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Trnka, Jan $u Laboratory for Metabolism and Bioenergetics, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Department of Biochemistry, Cell and Molecular Biology, Third Faculty of Medicine, Charles University, Prague, Czech Republic. Centre for Research on Diabetes, Metabolism and Nutrition, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
773    0_
$w MED00180950 $t PloS one $x 1932-6203 $g Roč. 11, č. 8 (2016), s. e0161413
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27537184 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20171025 $b ABA008
991    __
$a 20171025123109 $b ABA008
999    __
$a ok $b bmc $g 1255094 $s 992528
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 11 $c 8 $d e0161413 $e 20160818 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950
LZP    __
$a Pubmed-20171025

Najít záznam

Citační ukazatele

Možnosti archivace